BACKGROUND: The border zone of healing myocardial infarcts is an arrhythmogenic substrate, partly the result of structural and functional remodeling of the ventricular gap junction protein, Connexin43 (Cx43). Cx43 in arrhythmogenic substrates is a potential target for antiarrhythmic therapy. METHODS AND RESULTS: We characterized Cx43 remodeling in the epicardial border zone (EBZ) of healing canine infarcts 5 days after coronary occlusion and examined whether the gap junction-specific agent rotigaptide could reverse it. Cx43 remodeling in the EBZ was characterized by a decrease in Cx43 protein, lateralization, and increased Cx43 phosphorylation at serine (S) 368. Rotigaptide partially reversed the loss of Cx43 but did not affect the increase in S368 phosphorylation, nor did it reverse Cx43 lateralization. Rotigaptide did not prevent conduction slowing in the EBZ, nor did it decrease the induction of sustained ventricular tachycardia by programmed stimulation, although it did decrease the EBZ effective refractory period. CONCLUSIONS: We conclude that partial reversal of Cx43 remodeling in healing infarct border zone may not be sufficient to restore normal conduction or prevent arrhythmias.
BACKGROUND: The border zone of healing myocardial infarcts is an arrhythmogenic substrate, partly the result of structural and functional remodeling of the ventricular gap junction protein, Connexin43 (Cx43). Cx43 in arrhythmogenic substrates is a potential target for antiarrhythmic therapy. METHODS AND RESULTS: We characterized Cx43 remodeling in the epicardial border zone (EBZ) of healing canineinfarcts 5 days after coronary occlusion and examined whether the gap junction-specific agent rotigaptide could reverse it. Cx43 remodeling in the EBZ was characterized by a decrease in Cx43 protein, lateralization, and increased Cx43 phosphorylation at serine (S) 368. Rotigaptide partially reversed the loss of Cx43 but did not affect the increase in S368 phosphorylation, nor did it reverse Cx43 lateralization. Rotigaptide did not prevent conduction slowing in the EBZ, nor did it decrease the induction of sustained ventricular tachycardia by programmed stimulation, although it did decrease the EBZ effective refractory period. CONCLUSIONS: We conclude that partial reversal of Cx43 remodeling in healing infarct border zone may not be sufficient to restore normal conduction or prevent arrhythmias.
Authors: Kenneth W Spitzer; Andrew E Pollard; Lin Yang; Massimiliano Zaniboni; Jonathan M Cordeiro; Delilah J Huelsing Journal: J Cardiovasc Electrophysiol Date: 2006-05
Authors: James K Hennan; Robert E Swillo; Gwen A Morgan; James C Keith; Robert G Schaub; Robert P Smith; Hal S Feldman; Ketil Haugan; Joel Kantrowitz; Phil J Wang; Aqel Abu-Qare; John Butera; Bjarne D Larsen; David L Crandall Journal: J Pharmacol Exp Ther Date: 2005-12-12 Impact factor: 4.030
Authors: Lene N Axelsen; Martin Stahlhut; Shabaz Mohammed; Bjarne Due Larsen; Morten S Nielsen; Niels-Henrik Holstein-Rathlou; Søren Andersen; Ole N Jensen; James K Hennan; Anne Louise Kjølbye Journal: J Mol Cell Cardiol Date: 2006-05-05 Impact factor: 5.000
Authors: Stephan B Danik; Fangyu Liu; Jie Zhang; H Jacqueline Suk; Gregory E Morley; Glenn I Fishman; David E Gutstein Journal: Circ Res Date: 2004-10-21 Impact factor: 17.367
Authors: Gerard J J Boink; Jia Lu; Helen E Driessen; Lian Duan; Eugene A Sosunov; Evgeny P Anyukhovsky; Iryna N Shlapakova; David H Lau; Tove S Rosen; Peter Danilo; Zhiheng Jia; Nazira Ozgen; Yevgeniy Bobkov; Yuanjian Guo; Peter R Brink; Yelena Kryukova; Richard B Robinson; Emilia Entcheva; Ira S Cohen; Michael R Rosen Journal: Circ Arrhythm Electrophysiol Date: 2012-06-21
Authors: Olujimi A Ajijola; Robert L Lux; Anadjeet Khahera; OhJin Kwon; Eric Aliotta; Daniel B Ennis; Michael C Fishbein; Jeffrey L Ardell; Kalyanam Shivkumar Journal: Am J Physiol Heart Circ Physiol Date: 2017-01-13 Impact factor: 4.733
Authors: Gerard J J Boink; David H Lau; Iryna N Shlapakova; Eugene A Sosunov; Evgeny P Anyukhovsky; Helen E Driessen; Wen Dun; Ming Chen; Peter Danilo; Tove S Rosen; Nazira Őzgen; Heather S Duffy; Yelena Kryukova; Penelope A Boyden; Richard B Robinson; Peter R Brink; Ira S Cohen; Michael R Rosen Journal: Cardiovasc Res Date: 2012-02-27 Impact factor: 10.787
Authors: Angela C Cone; Gabriel Cavin; Cinzia Ambrosi; Hiroyuki Hakozaki; Alyssa X Wu-Zhang; Maya T Kunkel; Alexandra C Newton; Gina E Sosinsky Journal: J Biol Chem Date: 2014-02-05 Impact factor: 5.157
Authors: Elena Dolmatova; Gaelle Spagnol; Daniela Boassa; Jennifer R Baum; Kimberly Keith; Cinzia Ambrosi; Maria I Kontaridis; Paul L Sorgen; Gina E Sosinsky; Heather S Duffy Journal: Am J Physiol Heart Circ Physiol Date: 2012-09-14 Impact factor: 4.733
Authors: Michelle M J Nassal; Andreas A Werdich; Xiaoping Wan; Malcolm Hoshi; Isabelle Deschênes; David S Rosenbaum; J Kevin Donahue Journal: J Cardiovasc Electrophysiol Date: 2015-10-13